Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Anyuantang Pharmaceutical is a Chinese pharmaceutical company based in Xi'an, Shaanxi Province, specializing in the development, production, and sales of traditional Chinese medicine (TCM) formulations and modern pharmaceuticals. Established in 2020 as a wholly-owned subsidiary of Shaanxi Xinze Yifang Pharmaceutical, the company holds multiple NMPA drug approvals for various Chinese patent medicines, including Shenbei Kechuan Pills, Ganmao Pills, and Shenling Baizhu Powder. Shaanxi Anyuantang Pharmaceutical utilizes a contract manufacturing model, partnering with Shaanxi Lijun Modern Traditional Chinese Medicine Co., Ltd. for the production of its key products. The company's diverse portfolio targets therapeutic areas such as respiratory diseases, gastrointestinal disorders, cardiovascular health, and pediatrics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Anyuantang Pharmaceutical.